Forbes, B.; Goodacre, L.; Lansley, A.B.; Martin, A.R.; Palmer, H.; Patterson, C.; Roe, C.; Scherließ, R.
Advances in Nasal Biopharmaceutics to Support Product Development and Therapeutic Needs. Pharmaceutics 2025, 17, 1321.
https://doi.org/10.3390/pharmaceutics17101321
AMA Style
Forbes B, Goodacre L, Lansley AB, Martin AR, Palmer H, Patterson C, Roe C, Scherließ R.
Advances in Nasal Biopharmaceutics to Support Product Development and Therapeutic Needs. Pharmaceutics. 2025; 17(10):1321.
https://doi.org/10.3390/pharmaceutics17101321
Chicago/Turabian Style
Forbes, Ben, Lucy Goodacre, Alison B. Lansley, Andrew R. Martin, Helen Palmer, Claire Patterson, Chris Roe, and Regina Scherließ.
2025. "Advances in Nasal Biopharmaceutics to Support Product Development and Therapeutic Needs" Pharmaceutics 17, no. 10: 1321.
https://doi.org/10.3390/pharmaceutics17101321
APA Style
Forbes, B., Goodacre, L., Lansley, A. B., Martin, A. R., Palmer, H., Patterson, C., Roe, C., & Scherließ, R.
(2025). Advances in Nasal Biopharmaceutics to Support Product Development and Therapeutic Needs. Pharmaceutics, 17(10), 1321.
https://doi.org/10.3390/pharmaceutics17101321